FEATURED CONTENT
ORIGINAL REPORTS
Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial
Morton et al. | January 19, 2023
JUST ACCEPTED RAPID COMMUNICATION
Tarlatamab, a first-in-class DLL3-targeted bispecific T cell engager, in recurrent small-cell lung cancer: an open-label, phase 1 study
Paz-Ares et al. | January 23, 2023
SPONSORED CONTENT
